Intestinal epithelial cells (IECs) contribute to the regulation of intestinal homeostasis and inflammation through their interactions with the environment and host immune responses. Yet our understanding of IEC-intrinsic regulatory pathways remains incomplete. Here, we identify the guanine nucleotide exchange factor RABGEF1 as a regulator of intestinal homeostasis and innate pathways dependent on IECs. Mice with IEC-specific Rabgef1 deletion (called Rabgef1 IEC-KO mice) developed a delayed spontaneous colitis associated with the local upregulation of IEC chemokine expression. In mouse models of colitis based on Interleukin-10 deficiency or dextran sodium sulfate (DSS) exposure, we found that IEC-intrinsic RABGEF1 deficiency exacerbated development of intestinal pathology and dysregulated IEC innate pathways and chemokine expression. Mechanistically, we showed that RABGEF1 deficiency in mouse IECs in vitro was associated with an impairment of early endocytic events, an increased activation of the p38 mitogenactivated protein kinase (MAPK)-dependent pathway, and increased chemokine secretion. Moreover, we provided evidence that the development of spontaneous colitis was dependent on microbiota-derived signals and intrinsic MYD88-dependent pathways in vivo. Our study identifies mouse RABGEF1 as an important regulator of intestinal inflammation, MYD88-dependent IEC-intrinsic signaling, and chemokine production. This suggests that RABGEF1-dependent pathways represent interesting therapeutic targets for inflammatory conditions in the gut.
INTRODUCTION
The intestinal mucosa is particularly exposed to microorganisms and foreign antigens. Intestinal homeostasis thus relies on finely tuned interactions between the environment, intestinal epithelial cells (IECs) and host immune responses, which allow the host to assimilate nutrients and to tolerate commensal microorganisms and dietary antigens, while mounting appropriate defense responses against pathogens. [1] [2] [3] IECs critically contribute to the regulation of intestinal homeostasis and inflammation. 2, 3 Indeed, in addition to forming a physical barrier and eliciting efficient secretory defenses, IECs express a wide range of pattern recognition receptors (PRRs) 2,4-6 that can sense microbiota-derived signals and integrate them into appropriate homeostatic or defensive responses. 2, 3, 7 The abundance of symbiotic microorganisms necessitates that IECs express negative regulators of PRR signaling pathways in order to avoid aberrant immune responses and a break of tolerance, which can be associated with chronic inflammatory conditions such as inflammatory bowel diseases (IBDs). Experimental models of IBDs have substantially contributed to our understanding of IBD pathogenesis, which is thought to be driven by interactions between microbial, environmental, and host genetic factors. 2, 5, [8] [9] [10] [11] [12] RAB guanine nucleotide exchange factor 1 (RABGEF1) was first identified as a GDP/GTP exchange factor for the small GTPase Rab5, which regulates endocytosis and early endosome trafficking events. [13] [14] [15] [16] [17] RABGEF1 contains several functional domains, including a N-terminal A20-like zinc finger domain that can exhibit E3 ubiquitin ligase activity 18, 19 and a Vps9 domain promoting GEF activity for Rab5. [13] [14] [15] RABGEF1 is critical for health, as globally RABGEF1-deficient mice exhibit perinatal mortality. 20 In addition, we showed that RABGEF1 expression within skin epithelial cells (i.e., keratinocytes) is required to sustain optimal epidermal barrier functions and skin homeostasis in mice. 21 Based on evidence suggesting a homeostatic role of keratinocyte-intrinsic RABGEF1, we have speculated that this protein could also act as a regulator of homeostasis and inflammation at other epithelial surfaces, such as the intestine. In that site, colonization by microorganisms requires tight regulation of the intestinal epithelium in order to cope with the myriad of microbial stimuli and antigens.
RESULTS

IEC-specific Rabgef1 deletion promotes a spontaneous and delayed colitis
In the mouse colon, RABGEF1 protein was found to be highly expressed in IECs (Fig. 1a ) as well as in discrete cell clusters located in the submucosa, which may correspond to the myenteric plexus ( Fig. 1a, asterisks) . To investigate the functions of IEC-intrinsic RABGEF1 in vivo, Villin-Cre + ; Rabgef1 fl/fl mice with conditional Rabgef1 deletion within IECs were generated (called Rabgef1 IEC-KO mice hereafter) ( Fig. 1b) . Under conventional conditions of housing, Rabgef1 IEC-KO mice were born with a Mendelian ratio and did not develop any mortality ( Supplementary Fig. 1a ), weight loss ( Supplementary Fig. 1b ) or macroscopic intestinal abnormalities ( Supplementary Fig. 1c ) until the age of 12 months. Histopathological analyses of colon sections from 10-week-old mice did not reveal development of intestinal pathology in Rabgef1 IEC-KO mice ( Supplementary Fig. 1d, e ). However, similar analyses performed on 12-month-old mice showed signs of moderate inflammation (i.e., mucosal and submucosal inflammatory infiltrates) and epithelial damage (i.e., hyperplasia and erosion without goblet cell loss) in the colon of Rabgef1 IEC-KO mice as compared to controls ( Fig. 1c-e ), while no abnormalities were found in the small intestine ( Supplementary Fig. 2a-c) . We also analyzed other organs of aged Rabgef1 IEC-KO mice and did not find any obvious histological abnormalities ( Supplementary  Fig. 2d -l).
Epithelial RABGEF1 deficiency results in IEC-specific alteration of cytokine expression without systemic effects Next, we characterized IEC-intrinsic immune and barrier functions and features of systemic immune activation in Rabgef1 IEC-KO and littermate Rabgef1 fl/fl mice. Quantitative reverse transcription polymerase chain reaction (RT-qPCR) analyses of IECs from 12month-old mice revealed that RABGEF1-deficient IECs exhibited a higher expression of Tnfa, Ccl2, Cxcl1, and Cxcl2 as compared to the littermate counterparts, while the expression of other cytokines (Il6, Vegfa, Ccl11, and Ccl5) and Muc2 (coding for Mucin 2) was not affected by RABGEF1 deficiency (Fig. 2a ). Such effects were however not observed in IECs from 10-weekold Rabgef1 IEC-KO mice ( Supplementary Fig. 3 ). To evaluate intestinal permeability to luminal contents, plasma levels of fluorescein isothiocyanate (FITC) were measured following oral e Colon histopathological score (n = 10-12 mice/group). b, e Data are shown as mean + SEM, as well as individual values, and are pooled from 2 (b) or >3 (e) independent experiments. P values were calculated using a oneway ANOVA with Tukey's post hoc tests (b) and a Mann-Whitney test (e). *** P < 0.001. Scale bars: 100 μm (a, c); 20 μm (d). WT wild-type administration of FITC-dextran. Notably, no differences were found between 12-month-old Rabgef1 IEC-KO and littermate controls ( Fig. 2b ). Third, serum levels of several cytokines were not altered by IEC-restricted RABGEF1 deficiency in such mice (Fig. 2c ). These results indicate that epithelial RABGEF1 deficiency was associated with local changes in IEC innate responses, while no evidence of impaired intestinal permeability or systemic inflammation were observed. Epithelial RABGEF1 limits colon inflammation and pathology in IL-10-deficient mice The genetic model of colitis based on IL-10 deficiency has been extensively used to help dissecting the mechanisms of IBD. 22 It is thought to influence IEC responses [23] [24] [25] and promotes a spontaneous, microbiota-dependent colitis. 26, 27 To characterize the effects of IL-10 deficiency on IECs in our housing conditions, we performed mRNA-sequencing (RNA-seq) of FACS-sorted colonic IECs isolated from 10-week-old Il10 −/− and littermate Il10 +/+ mice and found that IECs clustered according to their genotype (i.e., Il10 −/− or Il10 +/+ mice) ( Supplementary Fig. 4a, b ). In addition, we found a significant enrichment, among genes upregulated in Il10 −/− IECs, of transcripts implicated in oxidative phosphorylation, protein translation and export, and ribosome function ( Supplementary Fig. 4c, d) , as well as MHC class II-related genes, chemokines, and genes implicated in the response to lipopolysaccharide (LPS) and the negative regulation of inflammation ( Supplementary Fig. 4e ). Conversely, genes downregulated in Il10 −/− IECs were shown to be involved in adherens/apical junctions, digestion or transmembrane transporter activity (Supplementary Fig. 4c, d) . These results support the idea that IECs isolated from Il10 −/− mice exhibit increased metabolic and innate immune activities associated with impaired barrier and digestive functions.
In order to address the contribution of IEC-intrinsic RABGEF1 in IL-10 deficiency-induced intestinal inflammation, Rabgef1 IEC-KO mice were generated on the Il10 −/− background, and the development of intestinal pathology was evaluated. At the age of 3-4 months, the weight and the colon lengths were not significantly different between Il10 −/− ; Rabgef1 IEC-KO and control Il10 −/− ; Rabgef1 fl/fl mice ( Supplementary Fig. 5 ). However, Il10 −/− ; Rabgef1 IEC-KO mice exhibited exacerbated signs of colon inflammation and damage as compared to controls ( Fig. 3 ). Indeed, microscopic analysis of colon sections revealed that Il10 −/− ; Rabgef1 IEC-KO mice had more severe inflammation (associated with transmural and dense inflammatory infiltrates), as well as more epithelial damage, sometimes developing into extensive ulcerated areas ( Fig. 3a ). Immunofluorescent staining of neutrophils with anti-myeloperoxydase (MPO) antibodies showed a higher number of neutrophils infiltrating the colon of Il10 −/− ; Rabgef1 IEC-KO mice as compared to controls (Fig. 3b, c) . In addition, a substantial and consistent loss of mucus-producing goblet cells was observed ( Fig. 3d ). As a consequence, a higher histopathological score was observed in the colon of Il10 −/− ; Rabgef1 IEC-KO mice vs. controls ( Fig. 3e ).
Within IECs, RABGEF1 deficiency was associated with increased expression of genes coding for pro-inflammatory cytokines (Il6, Tnfa, Vegfa, Ccl11, Ccl2, Cxcl1, and Cxcl2) and reduced expression of the Muc2 gene, consistent with the loss of goblet cells (Fig. 4a ). In addition, like the situation observed in 12-monthold Rabgef1 IEC-KO and littermates, intestinal permeability to FITCdextran and systemic levels of cytokines were not affected by RABGEF1 deficiency in this model (Fig. 4b, c ).
Epithelial RABGEF1 regulates susceptibility to DSS-induced colon damage and pathology Next, we assessed whether IEC-intrinsic RABGEF1 expression could be involved in the regulation of intestinal inflammation triggered by exogenous stimuli such as DSS. We used a model based on administration of 3% DSS in drinking water for 7 days, which promoted acute increases in numbers of neutrophils, eosinophils, monocytes/macrophages, and dendritic cells as compared to the baseline, a profile that was not observed in 10-week-old Il10 −/− mice ( Supplementary Fig. 6 ). Despite these differences between the two models, the transcriptomic profile of DSS-exposed colonic IECs evaluated by RNA-seq was strikingly similar to the one of IECs isolated from age-matched Il10 −/− animals ( Supplementary Fig. 7 ). Based on such findings, we decided to evaluate the contribution of epithelial RABGEF1 using this model.
Compared to Rabgef1 fl/fl mice, Rabgef1 IEC-KO mice exhibited liquid, sticky and bloody feces ( Fig. 5a ) and significantly shorter and highly inflamed colons ( Fig. 5b , c). Histopathological examination of colons from DSS-treated Rabgef1 IEC-KO mice revealed increased epithelial hyperplasia and crypt elongation, the presence of dense granulocyte-rich cell infiltrates in the submucosa, and extensive epithelial ulceration and transmural inflammation when compared to DSS-treated controls (Fig. 5d, e ), resulting in a more severe histopathological score ( Fig. 5f ). Two days after DSS treatment, when intestinal permeability to FITCdextran is known to be affected by DSS, 28 permeability to FITCdextran was, again, not different between Rabgef1 IEC-KO and control mice (Fig. 5g ). These results indicate that, similar to its role in the IL-10 deficiency model, RABGEF1 expression is also critical in limiting DSS-induced inflammation and damage. Altogether, our results so far support the idea that RABGEF1 deficiency promotes development of intestinal inflammation and locally exacerbates IEC innate responses.
RABGEF1 modulates intrinsic expression of genes implicated in IEC physiology, endocytosis, and innate immunity
To gain mechanistic insights into RABGEF1-dependent regulation of IEC responses, we performed RNA-seq analyses of FACS-sorted IECs from 10-week-old Il10 −/− ; Rabgef1 IEC-KO and littermate Il10 −/− ; Rabgef1 fl/fl mice. As shown in Fig. 6a , RABGEF1-deficient IECs were separated from the control counterparts across principal component (PC)1 (explaining 40% of the variance between samples). Using an adjusted P value (P adj ) < 10 −2 , a total of 102 genes were found to be differentially expressed (DE) between Il10 −/− ; Rabgef1 IEC-KO and Il10 −/− ; Rabgef1 fl/fl IECs ( Fig. 6b and Supplementary Table 1 ).
First, on the basis of MouseNet v2 network 29 and a bibliographical search, we found that several genes implicated in transmembrane transporter activity and metabolic processing of nutrients were downregulated in RABGEF1-deficient IECs (Fig. 6c ), supporting the idea that IECs' physiological functions were impaired when RABGEF1 was absent. Conversely, genes implicated in the regulation of innate immune pathways, such as the MAPK pathways or the NF-κB pathway, were upregulated in RABGEF1-deficient IECs (Fig. 6c ).
Second, gene set enrichment analysis (GSEA), used to identify biological signatures in IECs from Il10 −/− ; Rabgef1 IEC-KO mice as compared to those from Il10 −/− ; Rabgef1 fl/fl mice, revealed a significant enrichment, among genes downregulated in RABGEF1-deficient IECs, of genes involved in endocytic events ( Fig. 6d ). We also assessed the gene expression profiles of IECs from Rabgef1 IEC-KO and littermate control mice on the wild-type (WT) background by RNA-seq ( Supplementary Fig. 8a, b and Supplementary Table 2 ). Notably, we found a highly significant similarity in gene expression profiles of IECs from Rabgef1 IEC-KO mice under the IL-10-deficient and those under the WT background ( Supplementary Fig. 8c ), as well as a downregulation of endocytosis-related transcripts in IECs from Rabgef1 IEC-KO mice as compared to the control counterparts ( Supplementary  Fig. 8d ). These data support the conclusion that IECs exhibit alterations of their endolysosomal system when RABGEF1 is absent.
RABGEF1-deficient IECs display endosomal abnormalities in vitro
To support our RNA-seq-based observations at the protein level, we took advantage of immortalized mouse IECs, which display structural features of primary IECs and can functionally respond to microbial stimulation. 30 Lentiviral-based expression of RABGEF1 knockdown was induced in IECs (Supplementary Figs. 9 and 10). Using antibodies directed against the RABGEF1 endocytic effector Rab5, we showed that the distribution of Rab5 staining at steady- state was markedly different between RABGEF1-sufficient vs. RABGEF1-deficient IECs, with Rab5 being more diffusely distributed and less structurally organized when RABGEF1 was absent ( Fig. 7a ). After 60 min of LPS stimulation of RABGEF1-sufficient IECs, Rab5 staining intensity was increased and concentrated in polarized areas of the cell (Fig. 7a ). Conversely, Rab5 staining remained more diffuse and less polarized in LPS-stimulated RABGEF1-deficient IECs (Fig. 7a ).
In addition, we assessed the levels of early endosome antigen-1 (EEA-1) protein in RABGEF1-sufficient and RABGEF1-deficient IECs by Western blotting. EEA-1 is an early endosomal marker and effector of Rab5 whose levels have been shown to be reduced in Rab5-deficient cells 17 . We found that EEA-1 levels significantly increased following LPS stimulation of RABGEF1-sufficient IECs, supporting the occurrence of early endosomal events following LPS stimulation (Fig. 7b, c) . By contrast, we found that EEA-1 levels did not increase after LPS stimulation in RABGEF1-deficient IECs (Fig. 7b, c) . Altogether, these data indicate that Rab5-dependent endocytic events occur in IECs after LPS stimulation but that RABGEF1 deficiency disrupts such endocytic events. RABGEF1 regulates IEC-intrinsic p38-dependent signaling and chemokine production Next, we examined the signaling pathways mediating the interaction of LPS and the Toll like receptor (TLR)4. Upon LPS stimulation, RABGEF1 knockdown had no effects on the levels of phosphorylation of IκBα, an inhibitor of NF-κB whose phosphorylation is required for NF-κB activation (Fig. 8a, b) . 31 While increased levels of phosphorylated ERK were noted in RABGEF1 knockdown IECs, such activation effect was not restored in RABGEF1-rescued IECs (Fig. 8a, b ). However, after 5 or 15 min of LPS stimulation, RABGEF1 knockdown IECs exhibited increased phosphorylation levels of p38 MAPK as compared to those in RABGEF1-sufficient IECs, a signaling activation event that was not observed when RABGEF1 expression was restored (Fig. 8a, b) .
Functionally, such activation was associated with an increased ability of RABGEF1 knockdown IECs to produce the chemokines CCL2, CCL11, CXCL1, and CXCL2 as compared to the control or RABGEF1-rescued IECs (Fig. 8c) . Altogether, these data support the idea that RABGEF1 influences the TLR4-mediated p38 MAPKdependent signaling pathways and their associated productions of several chemokines in IECs.
Intestinal inflammation in Rabgef1 IEC-KO mice is mediated by intrinsic MYD88-dependent signaling and microbe-derived signals MYD88 mediates the signaling responses induced by activation of IL-1/IL-18/Toll receptor superfamily members to induce activation of NF-κB and MAPK pathways leading to the release of proinflammatory mediators. 32 Since RABGEF1 regulates the p38 MAPK pathway in response to LPS in vitro, which signals through MYD88, we wondered whether MYD88 signaling contributed to the phenotype observed in aged Rabgef1 IEC-KO mice. In order to test this, we generated and analyzed Rabgef1/Myd88 IEC-KO mice, in which IECs lack both MYD88 and RABGEF1. Notably, deletion of Myd88 in Rabgef1/Myd88 IEC-KO mice largely prevented the colitis observed in Rabgef1 IEC-KO counterparts (Fig. 9a, b) , which was associated with a similar IEC cytokine expression profile between Rabgef1/Myd88 IEC-KO mice and littermate controls (Fig. 9c) . These results support the conclusion that MYD88-dependent signaling mediates intestinal inflammation in Rabgef1 IEC-KO mice. The commensal microorganisms that colonize the colon after birth are critical components of host physiology and immune homeostasis in healthy individuals, but can also contribute to pathological processes in a dysregulated system 1, 33, 34 . IECs express a wide range of TLRs, which sense and transduce microbiota-derived signals via MYD88, except for TLR3 4, 7, 31 . Since the delayed colitis of Rabgef1 IEC-KO mice was dependent on MYD88, we sought to determine the contribution of the microbiome in this context.
First, we wondered whether IEC-specific RABGEF1 depletion could induce alterations in the colon microbial composition. Therefore, we performed sequencing of bacterial 16S ribosomal RNA genes (16S rRNA-seq) to compare the composition of the microbiota found in the colon lumen of Rabgef1 IEC-KO and littermate Rabgef1 fl/fl controls at the age of 10 months. Multidimensional scaling and unsupervised hierarchical clustering did not reveal any genotype-dependent clustering (Fig. 10a, b) , and bacterial diversity was found to be similar in the colon of Rabgef1 IEC-KO as compared to the control counterparts ( Fig. 10c ). In addition, colon microbiota composition was not different between Rabgef1 IEC-KO and Rabgef1 fl/fl control mice (Fig. 10d ), supporting that epithelial RABGEF1 deficiency does not induce changes in the gut bacterial composition.
Second, we continuously fed 6-month-old Rabgef1 IEC-KO and littermate controls with autoclaved water with or without antibiotics (AB) for a period of 4 months, and colon histopathological scoring was performed at the end of the treatment. Notably, we found that antibiotic treatment significantly reduced the features of colitis and the histopathological score in ABtreated Rabgef1 IEC-KO mice as compared to the untreated counterparts ( Fig. 10e, f) , supporting the conclusion that microbiotadependent signals are involved in the delayed colitis that develops in aged Rabgef1 IEC-KO mice.
DISCUSSION
We have identified herein a novel role for the guanine exchange factor RABGEF1 in the regulation of IEC functions and intestinal inflammation in vivo. Using mice conditionally deficient for Rabgef1 in IECs, we have provided experimental evidence that epithelial RABGEF1 deficiency promotes development of a microbiota-and MYD88-dependent colitis with age. Such colitis was associated with an upregulation of IEC-intrinsic transcripts coding for pro-inflammatory cytokines and chemokines. Notably, however, no defects in intestinal barrier permeability, nor features of systemic immune activation, were observed in 12-month-old Rabgef1 IEC-KO mice. This supports the idea that epithelial RABGEF1 regulates events that are restricted to the gut mucosa, without substantial systemic effects. Interestingly, it has been reported in some mouse models that intestinal and systemic pathology could be regulated by distinct mechanisms and disconnected from each other. 35 To investigate the role of epithelial RABGEF1 in the context of intestinal inflammation, we used two distinct models of colitis, initiated either by a dysregulated host immune response (i.e., IL-10 deficiency) or by an epithelial-eroding agent (i.e., DSS). The fact that IECs from 10-week-old Il10 −/− mice or from DSS-exposed WT mice shared a strikingly similar profile supports the conclusion that the IEC response to colitogenic triggers, whether they are endogenous (i.e., IL-10 deficiency) or exogenous (i.e., DSS), is conserved. This is particularly interesting, since the IL-10 deficient and the DSS models are different in several aspects, e.g., chronic vs. acute, and endogenous immune trigger vs. exogenous trigger, respectively. Given the differences observed in the recruitment of immune cells between the two models, it seems likely that the eroding properties of DSS and the subsequent release of damageassociated signals from dying epithelial cells initially contribute to the acute immune cell infiltration upon DSS exposure, as opposed to the situation in IL-10-deficient mice. However, the features of DSS-induced pathology, including the cellular immune profile in the colon, are thought to be influenced by many factors, including the dose and duration of DSS treatment, the gender and genetic background of the host, and the microbial status or the Fig. 8 RABGEF-dependent regulation of p38-dependent signaling and chemokine production in IECs. Immortalized primary mouse IECs transduced with lentiviral plasmids encoding nontarget (NT) and Rabgef1 single guide (sg)RNA and Cas9 (sgRNA NT and sgRNA Rabgef1, respectively), and RABGEF1-deficient IECs (sgRNA Rabgef1) transduced with plasmids encoding Rabgef1 to restore RABGEF1 expression (Rescued RABGEF1) were used. a Representative Western Blots and b protein quantification showing the levels of the indicated phosphoproteins and total proteins at different times following LPS stimulation. Results are representative of similar results obtained in each of three experiments performed with three separate batches of cells. c Cytokine concentrations measured by Luminex assay in the supernatants of media (Vehicle)-or LPS-stimulated IECs. Data are mean + SEM and are pooled from two independent stimulation experiments performed with two separate batches of cells. P values were calculated using a two-way ANOVA test followed by Tukey's post hoc tests for multiple comparisons. ** P < 0.01; *** P < 0.001; nd not detected housing conditions, which makes comparisons between studies difficult. 36, 37 During either form of colitis, IEC-specific RABGEF1 deficiency exacerbated several cardinal features of colon pathology and was associated with increased expression of pro-inflammatory cytokines, but did not impact intestinal permeability and systemic levels of pro-inflammatory cytokines, supporting the existence of RABGEF1-dependent local regulatory mechanisms. Moreover, genes involved in the regulation of the endolysosomal system were found to be downregulated in IECs from Rabgef1 IEC-KO mice as compared to controls, both under the Il10 −/− and the WT background. This suggests that the GEF activity of RABGEF1 for the GTPase Rab5, critical for the biogenesis of endosomes 17 , mediates such effects in IECs in vivo.
The transcriptomic analyses of RABGEF1-deficient IECs also suggested a possible involvement of RABGEF1 in regulating MAPK-or NF-κB-dependent innate signaling. Specifically, we used an in vitro tool to investigate the potential RABGEF1-dependent regulation of such pathways. Immortalized mouse primary IECs were chosen because they allow analysis of innate immune functions 30 , but circumvent the restricted availability and homogeneity of primary cells and organoids, respectively, and also avoid the structural and functional alterations often present in intestinal cell lines. Using this model, we have shown on the one hand that RABGEF1 knockdown markedly altered Rab5-dependent endocytic events, at steady-state and upon LPS stimulation. On the other hand, we found that, upon LPS stimulation, RABGEF1 specifically prevented activation of p38 MAPK and downregulated the production of several chemokines, including CCL2, CXCL1, and CXCL2, consistent with the transcriptomic profile of RABGEF1-deficient IECs in vivo.
Notably, RABGEF1-sufficient IECs seemed particularly hyporesponsive to LPS stimulation in our experimental setting, which reflects well the hypo-responsiveness of IECs to LPS and other TLR ligands in vivo. [38] [39] [40] However, when IEC-intrinsic RABGEF1 expression was knocked down, LPS responsiveness was potentiated, leading to aberrant activation of the p38 MAPK and increased chemokine production. These data are consistent with the hypothesis that RABGEF1 may act as a regulator of IEC innate responsiveness in vivo, and that such responsiveness is compromised when epithelial RABGEF1 is absent, which would contribute to increased chemokine expression and the exaggerated inflammation observed in Rabgef1 IEC-KO mice. In this regard, it is interesting to note that the monocyte chemoattractant CCL2 and the neutrophil chemoattractants CXCL1 and CXCL2 are thought to be involved in human or experimental IBD, [41] [42] [43] [44] and the p38 MAPK pathway has been shown to specifically control the expression of chemokines within IECs. 45, 46 The delayed development of colitis in Rabgef1 IEC-KO mice suggested that environmental factors may mediate disease susceptibility in those animals, and microbe-derived signals arguably represented appealing candidates. Indeed, Rabgef1 IEC-KO mice developed intestinal inflammation at a site of heavy microbial exposure (i.e., the colon) but did not have detectable pathology in the small intestine where the bacterial load is much lower. Moreover, we showed that the spontaneous colitis of Rabgef1 IEC-KO mice was MYD88-dependent, and it is well-known that many microbe-associated patterns can activate TLRs through the adapter protein MYD88 47, 48 . By analyzing the microbial composition of the colons of Rabgef1 IEC-KO mice and by treating them with AB, we have provided evidence that the intestinal inflammation that develops in aged Rabgef1 IEC-KO mice depends on microbe-derived commensal signals. In younger mice, it may be that regulatory mechanisms are more effective in preventing development of colitis.
Previous work supports the conclusion that RABGEF1 can regulate many different pathways of innate immunity. In mast cells in vitro, RABGEF1 has been shown to regulate FcεRI-dependent activation of Ras and ERK 20 and SCF-dependent activation of ERK and JNK. 49 In the skin, we have demonstrated that keratinocyte RABGEF1 can maintain skin homeostasis by regulating intrinsic IL1R-MYD88-NF-κB-dependent signaling pathways independently of the skin microbiota. 21 The current study indicates that epithelial RABGEF1 can also regulate microbiota-and MYD88-dependent intestinal inflammation and p38 MAPK-dependent signaling and chemokine production in IECs. We cannot exclude the possibility that IL-1β contributes to MYD88-dependent inflammation in Rabgef1 IEC-KO mice. However, RABGEF1-dependent regulatory pathways appear to exhibit differences in functional and interactive properties in epidermal keratinocytes, IECs and mast cells, suggesting that there may be tissue-and cell-specific mechanisms mediating different RABGEF1 effects.
The precise mechanisms by which the activities of RABGEF1 regulate the activation of innate immune pathways, and the expression of cytokines, in IECs are still unclear. Nevertheless, our data are in accord with the hypothesis that the GEF activity for Rab5 may contribute to these effects. Indeed, we have demonstrated that deletion of RABGEF1 can markedly alter Rab5dependent endocytic events, as well as TLR4-MYD88-dependent signaling pathways, in IECs. Since activation of TLR4 by LPS is regulated by endosomal-mediated endocytosis, which requires Rab5 activity that is regulated by RABGEF1 [13] [14] [15] [16] [17] 48 , RABGEF1 deficiency may downregulate LPS-induced receptor-mediated endocytosis. Because RABGEF1 represents an important negative regulator of TLR4 signaling, RABGEF1 deficiency may promote the increased activation of LPS-dependent pathways, resulting in an increased cytokine expression in IECs.
Stimulation of the TLR4-MYD88-dependent pathway by LPS also can activate several transcription factors, including NF-κB, AP-1, and CREB 31, 48 . In our signal transduction analyses, we showed that stimulation of RABGEF1-deficient IECs with LPS did not increase levels of p-IκBα, suggesting that the NF-κB pathway is not involved in the observed effect elicited by RABGEF1 deficiency. Similarly, our signaling studies also showed that ERK MAPK was not involved in the LPS-induced effect observed with these cells, suggesting that the AP-1 pathway is likewise not directly involved. However, levels of phosphorylation of p38 MAPK were significantly enhanced by LPS stimulation in RABGEF1-deficient IECs, suggesting that the CREB transcription factor pathway is involved in mediating the cytokine transcription effects during the TLR4dependent activation of IECs 31, 48 . Obviously, future detailed mechanistic studies using epidermal keratinocytes, mast cells and IECs expressing different RABGEF1 domain mutants will help in investigating how different domains of RABGEF1 are involved in such effects and the precise molecular mechanisms underlying the regulatory functions of RABGEF1.
In conclusion, our study identifies a previously unknown function for RABGEF1 protein in the regulation of MYD88dependent intestinal inflammation and IEC innate pathways in mice. It is currently unknown whether dysregulated epithelial RABGEF1 expression also contributes to intestinal pathology in IBD in humans. However, in 2013, Montero-Meléndez and colleagues performed microarray gene expression profiling of colon biopsies from a small cohort of IBD patients in search of predictive genomic signatures, and identified RABGEF1 transcript level as a clinically relevant predictor for classifying IBD patients, with glucocorticoid-resistant patients exhibiting the lowest RABGEF1 expression. 50 Together with our study, these data suggest that RABGEF1-dependent regulatory mechanisms may represent promising therapeutic targets in the context of IBD.
METHODS
Mice C57BL/6 Rabgef1 fl/fl mice were previously described. 21 Transgenic C57BL/6 Villin-Cre (B6.Cg-Tg(Vil1-cre)997Gum/J), 51 Il10 −/− (B6.129P2-Il10 tm1Cgn /J) and Myd88 fl/fl (B6.129P2[SJL]-Myd88 tm1-Defr /J) mice were from The Jackson Laboratory (Bar Harbor, USA). Mice were housed under specific pathogen free (SPF) conditions and maintained in a 12-h light-dark cycle with food and water ad libitum. Age-matched littermate mice were used for experiments throughout the study. All animal experiments described in this study were carried out with the approval of the Institutional Animal Care and Use Committee of Liege University. The "Guide for the Care and Use of Laboratory Animals", prepared by the Institute of Laboratory Animal Resources, National Research Council, and published by the National Academy Press, as well as European and local legislations, were followed carefully.
Reagents and antibodies
Details about reagents and antibodies can be found in the Supplementary material.
Immunostaining and confocal microscopy Paraffin-embedded intestinal sections were deparaffinized, rehydrated, and heat-induced epitope retrieval was performed in sodium citrate buffer. After blocking, samples were incubated overnight at 4°C with primary antibodies. Secondary antibody staining was performed at room temperature.
For immunostaining of IECs in vitro, IECs were cultured on slides for 24 h. Slides were methanol-fixed and permeabilized before staining with primary and secondary antibodies.
Images were acquired using a Leica SP5 (Wetzlar, Germany) confocal laser-scanning microscope. Additional Details can be found in the Supplementary material.
Assessment of intestinal permeability
To evaluate intestinal permeability, FITC-dextran (FD4, Merck, Darmstadt, Germany) was administered by gastric gavage to fasting mice (4 h food and water fasting, 0.6 mg/g diluted in phosphate-buffered saline (PBS)). Four hours later, plasma was collected and plasma levels of FITC were measured by spectrophotometry.
Quantitative RT-PCR on IECs After IEC FACS sorting, RNA was extracted and reverse-transcribed into cDNA, and PCR reactions were performed in duplicate. Primer sequences can be found in Supplementary Table 3 . Data were normalized to the housekeeping genes Hprt and Ppib in the same sample. Additional details can be found in the Supplementary material.
Quantification of serum cytokines
Blood was collected from the tail vein and sera were assayed for CXCL1, CXCL2, GM-CSF, IL1-β, IL-6, VEGF, and TNF-α using Luminex Mouse Magnetic Assay (R&D, Minneapolis, USA), according to the manufacturer's recommendations.
Colon histopathological scoring
For evaluation of colon pathology in antibiotic-treated or untreated Rabgef1 IEC-KO , Rabgef1/Myd88 IEC-KO and control counterparts at steady-state, on the WT or Il10 −/− background, the scoring system described in the report of Dieleman et al. 52 was adapted as described in the Supplementary material.
Mouse model of DSS-induced colitis
Experiments involving DSS exposure involved between 8-and 12week-old female mice. Acute colitis was induced by addition of 3% DSS (DSS Colitis grade, MP biomedicals, Santa Ana, USA) to the drinking water for 7 days. Stool consistency was evaluated at day 7 during 4 h and mice were then sacrificed to perform a macroscopic evaluation of the colons and for histopathological analyses. The severity of DSS-induced colitis was evaluated, as Epithelial RABGEF1 deficiency promotes intestinal inflammation by. . . S El Abbas et al.
previously reported 53 and as described in the Supplementary material.
In vitro IEC culture and stimulation Mouse CI-muINTEPI cells (InSCREENeX, Braunschweig, Germany) were cultured in muINTEPI complete medium (InSCREENeX). Plates were precoated with collagen solution (InSCREENeX) for 2 h and washed with PBS before use. When cultured cells reached 80% confluence, NT control, RABGEF1-knockdown and RABGEF1rescued IECs were seeded in 24-well plates (4 × 10 5 cells). For confocal microscopy analysis, cells were cultured and stimulated as described above. For Western blot studies, cells were stimulated with LPS (100 ng/ml) for 5, 15, or 60 min; for cytokine measurements, cells were stimulated with LPS for 6 or 24 h and cell culture supernatants were assayed for CCL2, CCL11, CXCL1, CXCL2, and TNF-α using Luminex Mouse Magnetic Assay (R&D, Minneapolis, USA).
Western blotting
Mouse IECs were lysed in lysis Buffer (3.03 g TRIS pH 7.5 + 0.19 g EDTA + 5 mL NP-40 + 6 g NaCl in 500 mL DQ water) supplemented with Complete ™ Protease Inhibitor Cocktail (Roche, Basel, Switzerland) and PhosSTOP ™ Phosphatase Inhibitor Cocktail (Roche, Basel, Switzerland). Protein concentrations in the resulting lysates were measured using the Pierce ™ BCA Protein Assay Kit (ThermoFisher Scientific, Waltham, USA). Totally, 50 µg proteins were loaded in 4-20% Mini-PROTEAN ® TGX ™ Gel (Bio-rad, Hercules, USA) and electroblotted onto Invitrolon polyvinylidene fluoride membranes (Novex, ThermoFisher Scientific, Waltham, USA). Membranes were blocked in 5% nonfat dry milk in Tris-buffered saline-Tween 20 (0.1%) buffer and then probed with primary antibodies in 5% bovine serum albumin-tris-buffered saline-Tween 20 (0.1%) buffer. Equal loading was confirmed by probing for actin, vinculin or HSP-90α.
Antibiotic treatment
Six-month-old Rabgef1 IEC-KO mice and Rabgef1 fl/fl littermate controls were fed autoclaved water with or without enrofloxacin 1% (Baytril, Bayer) for 4 months.
Other methods See the Methods section in Supplementary material for cell isolation, staining and flow cytometry, assessment of Rabgef1 deletion by quantitative PCR, sample preparation and histology, high-throughput mRNA-sequencing, GSEA, lentiviral-based RAB-GEF1 knock down and rescuing of mouse IECs, 16S rRNA gene sequencing and metagenomic analyses.
Statistical analyses
Respect of the assumptions of normal distribution of residuals and homoscedasticity were verified. Unless otherwise indicated, data are presented as mean + SEM, as well as individual values, from independent experiments and were pooled for analysis in each data panel. Statistical analyses were performed using Prism 6 (GraphPad Software, La Jolla, USA), except for RNA-seq data, for which the R package "DESeq2" was used. We performed the Mantel-Cox test, one-way or two-way ANOVA with Tukey's post hoc tests for multiple comparisons, and Mann-Whitney or unpaired two-tailed Student's t tests as mentioned in the respective figure legends. We considered a P value lower than 0.05 as significant. * P < 0.05; ** P < 0.01, *** P < 0.001; ns not significant.
